Zobrazeno 1 - 10
of 7 194
pro vyhledávání: '"Mahendra Pal Singh"'
Autor:
Moiz Tundawala
Publikováno v:
Asian Journal of Comparative Law. 15:402-405
Autor:
Pratyush Kumar
Publikováno v:
Indian Journal of Public Administration. 64:756-768
Mahendra Pal Singh, The Indian Yearbook of Comparative Law 2016. New Delhi: Oxford University Press, 2017, 526 pp., ₹1,002.
Publikováno v:
Mountain Research and Development, 2012 Feb 01. 32(1), 99-100.
Externí odkaz:
https://www.jstor.org/stable/mounresedeve.32.1.99
Publikováno v:
Mountain Research and Development, 2010 Feb 01. 30(1), 56-57.
Externí odkaz:
https://www.jstor.org/stable/mounresedeve.30.1.56
Autor:
Kumar, Pratyush
Publikováno v:
Indian Journal of Public Administration; December 2018, Vol. 64 Issue: 4 p756-768, 13p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Monika Bhardwaj, Jennifer J. Lee, Amanda M. Versace, Sandra L. Harper, Aaron R. Goldman, Mary Ann S. Crissey, Vaibhav Jain, Mahendra Pal Singh, Megane Vernon, Andrew E. Aplin, Seokwoo Lee, Masao Morita, Jeffrey D. Winkler, Qin Liu, David W. Speicher, Ravi K. Amaravadi
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 8 (2023)
Lysosomal inhibition elicited by palmitoyl-protein thioesterase 1 (PPT1) inhibitors such as DC661 can produce cell death, but the mechanism for this is not completely understood. Programmed cell death pathways (autophagy, apoptosis, necroptosis, ferr
Externí odkaz:
https://doaj.org/article/fad0eadd0ff64a57986f4c0b83cbe4f7
Autor:
Ravishankar Ramachandran, Vivek Bhosale, Himanshu Reddy, Virendra Atam, MMA Faridi, Jalees Fatima, Vaibhav Shukla, Zaw A Khan, Hana Khan, Vikram Singh, Mahendra Pal Singh Negi, Mukesh Srivastava, Ajay Kumar Srivastava, Chandra Bhushan Tripathi, Nayan Ghosh, Nilanjana Majumdar, Raj Kamal Tripathi, Srikanta Kumar Rath, Prabhat Ranjan Mishra, Sharad Sharma, Tapas K Kundu
Publikováno v:
International Journal of Infectious Diseases, Vol 115, Iss , Pp 62-69 (2022)
Objective: To test efficacy, safety and tolerability of Umifenovir in non-severe COVID-19 adult patients. Methods: We carried out randomized, double-blind, placebo-controlled, multicenter, phase III trials involving adult (18-75 years), non-severe CO
Externí odkaz:
https://doaj.org/article/dcd93c210c8347afac38aa1f14db76ae
Autor:
Ramachandran, Ravishankar, Bhosale, Vivek, Reddy, Himanshu, Atam, Virendra, Faridi, MMA, Fatima, Jalees, Shukla, Vaibhav, Khan, Zaw A, Khan, Hana, Singh, Vikram, Negi, Mahendra Pal Singh, Srivastava, Mukesh, Srivastava, Ajay Kumar, Tripathi, Chandra Bhushan, Ghosh, Nayan, Majumdar, Nilanjana, Tripathi, Raj Kamal, Rath, Srikanta Kumar, Mishra, Prabhat Ranjan, Sharma, Sharad, Kundu, Tapas K
Publikováno v:
In International Journal of Infectious Diseases February 2022 115:62-69
Autor:
Sadashiv, Anupama Modi, Manoj Khokhar, Praveen Sharma, Rajnish Joshi, Sudhanshu Shekhar Mishra, Rajay N Bharshankar, Sunita Tiwari, Pankaj Kumar Singh, Vivek Vidyadhar Bhosale, Mahendra Pal Singh Negi
Publikováno v:
Journal of Obesity & Metabolic Syndrome, Vol 30, Iss 3, Pp 304-311 (2021)
Background : It is well established that obesity is a major health risk in diabetes and associated diseases. Epigenetic changes, specially DNA methylation, play an important role in regulation of adipokines. The objective of the present study was to
Externí odkaz:
https://doaj.org/article/f7f4fe609f1f4bd0be75148bc9d06953